SPRIM Global Investments and OneIM Forge New Venture to Boost Clinical Trials Funding SPRIM Global Investments and OneIM unveil a $300 million joint venture aimed at accelerating funding for clinical studies, enhancing biotech and medtech innovations.

SPRIM Global Investments and OneIM Forge New Venture to Boost Clinical Trials Funding #USA #New_York #OneIM #SPRIM_Global_Investments #TrialCap